Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Jefferies' top picks in the CRDMO space are Sai Lifesciences and Divi’s for strong execution and healthy growth outlook.

Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for ...

Vinay Rajani of HDFC Securities says Divis Labs share price has broken out from the box pattern on the daily chart with the ...

Multiple experts are converging on select pharma, FMCG, media, and financial services counters. Key names on today’s radar ...

Nifty Pharma index closed up 1.69% at 23126.85 today. The index has gained 1.00% over last one month. Among the constituents, Divis Laboratories Ltd added 4.38%, Ipca Laboratories Ltd rose 4.01% and ...

Divi’s Laboratories shares gained over 3 per cent as analysts flagged 2026 as a potential inflection point, driven by a ...

Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...

The 64-page bill proposes a new certification exam for ‘accredited investors’ and would allow 403(b) plans to invest in the same products as 401(k) plans.

The stock of Divi’s Laboratories (₹6,473.50) has been moving in a long range between ₹5,250 and ₹7,000 in the last one year. Immediate support levels are at ₹6,359 and ₹6,200. Nearest resistances are ...

Divi’s Laboratories has reported a positive regulatory development, confirming that the US Food and Drug Administration (USFDA) has successfully completed a comprehensive cGMP inspection at the ...